(Q46955705)

26 December 2017

title

Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics (English)

1 reference

26 December 2017

1 reference

1 reference

Martín J García-González

1

1 reference

26 December 2017

Alberto Domínguez-Rodríguez

2

1 reference

26 December 2017

Julio J Ferrer-Hita

3

1 reference

26 December 2017

Pedro Abreu-González

4

1 reference

26 December 2017

Miguel Bethencourt Muñoz

5

1 reference

26 December 2017

publication date

21 February 2006

1 reference

26 December 2017

European Journal of Heart Failure

published in

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

issue

7

1 reference

26 December 2017

page(s)

723-728

1 reference

26 December 2017

Inotropic therapy for heart failure: an evidence-based approach.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Levosimendan: a review of its use in the management of acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Levosimendan: Implications for Clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Role of cardiac power in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Cardiogenic shock complicating acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

The stunned myocardium: prolonged, postischemic ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.007

10.1016/J.EJHEART.2006.01.007

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017